Clotting nsg 210 Questions with Detailed Verified
Answers
Pulmonary Circulation Ans: Blood pumped from the right side of the heart to the
lungs
Systemic Circulation Ans: Blood pumped from the left side of the heart to body
tissues
Arteries vs. Veins Ans: Arteries carry oxygenated blood; veins carry deoxygenated
blood
Atherosclerotic Plaque Ans: Buildup of fats, cholesterol, and other substances in and
on artery walls
Intermittent Claudication Ans: Pain due to inadequate blood flow during exercise
Rest Pain Ans: Persistent pain in the foot indicating severe arterial insufficiency
Rubor Ans: Reddish-blue discoloration indicating severe arterial damage
ABI Ans: Ankle systolic blood pressure ratio to arm systolic blood pressure
Arteriogram Ans: Angiography image showing vascular obstructions or aneurysms
Lymphoscintigraphy Ans: Radioactive colloid injection to visualize lymphatic flow
Raynaud's Phenomenon Ans: Intermittent vasoconstriction causing coldness and pain
in extremities
Primary Raynaud's Ans: Occurs without an underlying disease
Secondary Raynaud's Ans: Occurs with an underlying disease, more common in
women
VTE Ans: Venous thromboembolism, includes DVT and PE
, Virchow Triad Ans: Factors contributing to VTE: endothelial damage, venous stasis,
altered coagulation
Effort Thrombosis Ans: Upper extremity thrombosis due to repetitive motion
Phlegmasia Cerulea Dolens Ans: Massive iliofemoral venous thrombosis causing
extremity swelling
Superficial Thrombophlebitis Ans: Pain, redness, and warmth in superficial veins
Anticoagulant Therapy Ans: Medication to prevent clot formation and extension
Thrombolytic Therapy Ans: Treatment to dissolve clots, used in unstable PE
Pulmonary Embolism Ans: Obstruction of pulmonary artery by a dislodged thrombus
Alveolar Dead Space Ans: Increased space due to pulmonary artery obstruction
Dyspnea Ans: Difficulty breathing, common symptom of PE
Tachypnea Ans: Increased respiratory rate, common sign of PE
Antiplatelet Agents Ans: Medications inhibiting platelet adhesion and aggregation
Antiplatelet agents Ans: Inhibit platelet adhesion and aggregation by blocking receptor
sites
Abciximab Ans: Intravenous antiplatelet agent
Anagrelide Ans: Oral antiplatelet agent, caution with thrombocytopenia history
Clopidogrel Ans: Oral antiplatelet with CYP2C19 metabolism warning
Anticoagulants Ans: Interfere with clotting cascade and thrombin formation
© Get it right 2025 Getaway - Stuvia US All rights reserved
Answers
Pulmonary Circulation Ans: Blood pumped from the right side of the heart to the
lungs
Systemic Circulation Ans: Blood pumped from the left side of the heart to body
tissues
Arteries vs. Veins Ans: Arteries carry oxygenated blood; veins carry deoxygenated
blood
Atherosclerotic Plaque Ans: Buildup of fats, cholesterol, and other substances in and
on artery walls
Intermittent Claudication Ans: Pain due to inadequate blood flow during exercise
Rest Pain Ans: Persistent pain in the foot indicating severe arterial insufficiency
Rubor Ans: Reddish-blue discoloration indicating severe arterial damage
ABI Ans: Ankle systolic blood pressure ratio to arm systolic blood pressure
Arteriogram Ans: Angiography image showing vascular obstructions or aneurysms
Lymphoscintigraphy Ans: Radioactive colloid injection to visualize lymphatic flow
Raynaud's Phenomenon Ans: Intermittent vasoconstriction causing coldness and pain
in extremities
Primary Raynaud's Ans: Occurs without an underlying disease
Secondary Raynaud's Ans: Occurs with an underlying disease, more common in
women
VTE Ans: Venous thromboembolism, includes DVT and PE
, Virchow Triad Ans: Factors contributing to VTE: endothelial damage, venous stasis,
altered coagulation
Effort Thrombosis Ans: Upper extremity thrombosis due to repetitive motion
Phlegmasia Cerulea Dolens Ans: Massive iliofemoral venous thrombosis causing
extremity swelling
Superficial Thrombophlebitis Ans: Pain, redness, and warmth in superficial veins
Anticoagulant Therapy Ans: Medication to prevent clot formation and extension
Thrombolytic Therapy Ans: Treatment to dissolve clots, used in unstable PE
Pulmonary Embolism Ans: Obstruction of pulmonary artery by a dislodged thrombus
Alveolar Dead Space Ans: Increased space due to pulmonary artery obstruction
Dyspnea Ans: Difficulty breathing, common symptom of PE
Tachypnea Ans: Increased respiratory rate, common sign of PE
Antiplatelet Agents Ans: Medications inhibiting platelet adhesion and aggregation
Antiplatelet agents Ans: Inhibit platelet adhesion and aggregation by blocking receptor
sites
Abciximab Ans: Intravenous antiplatelet agent
Anagrelide Ans: Oral antiplatelet agent, caution with thrombocytopenia history
Clopidogrel Ans: Oral antiplatelet with CYP2C19 metabolism warning
Anticoagulants Ans: Interfere with clotting cascade and thrombin formation
© Get it right 2025 Getaway - Stuvia US All rights reserved
